Full Press Release Details
IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First in Class Pol Theta Helicase Inhibitor Development Candidate.
IDYA
IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First in Class Pol Theta Helicase Inhibitor Development Candidate
Key Takeaway: IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First in Class Pol Theta Helicase Inhibitor Development Candidate